LONG +3x Stock Opportunity

Outlier Capital · Outlier Capital · April 22, 2026 at 12:09 · ⏱ 4 min read  | Read on Substack ↗
Summary
The article argues that Nynomic (M7U) is a messy, underfollowed small-cap with a recovery setup after a tough 2025 year. The author highlights improving Q4 2025 trends, management guidance for FY2026 margin recovery, and the potential for the LayTec subsidiary to benefit from rising optoelectronics demand. The market still prices the stock for past problems, creating an opportunity if the turnaround materializes.
  • Nynomic reported weak preliminary FY2025 results (€92.6M revenue, ~2% EBIT margin) but Q4 showed improvement.
  • Management guides FY2026 revenue of €100–105M and EBIT margin of 6%–8%, signaling recovery.
  • Key subsidiary LayTec provides metrology for compound semiconductors and silicon thin films, an area tied to AI-era photonics.
  • AIXTRON's strong Q1 2026 order intake (up ~30% YoY) supports the thesis that optoelectronics demand is inflecting.
  • The author believes the market is backward-looking and ignores the cost restructuring and potential visibility from the order backlog.
  • Risks include volatile capex, geopolitical tensions, and the need to prove the recovery is durable.
Read time 4 min
Length 4,955 chars
Category finance
Trade Ideas
Outlier Capital Substack author, Outlier Capital
The author is long Nynomic as a recovery play, believing the market undervalues the company's operational turnaround and exposure to growing optoelectronics demand via LayTec.
More from Outlier Capital

This newsletter, published April 22, 2026, features Outlier Capital discussing M7U.DE. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: Outlier Capital  · Tickers: M7U.DE